Mediterranean Journal of Hematology and Infectious Diseases (Apr 2022)
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID
Abstract
Keywords
Mediterranean Journal of Hematology and Infectious Diseases (Apr 2022)